$IMAX

Fernandes Natasha sold $1.1M of IMAX

Fernandes Natasha (Chief Financial Officer & EVP) sold 20,000 shares of IMAX CORP (IMAX) at $54.63 ($1.09M total) on 2026-08-24.

Original reporting
SEC EDGAR · Fernandes Natasha
Published Aug 26, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 8:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IMAX
Bearish
medium confidence
Mentioned
$IMAX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IMAXBearishLow
01

Why it matters

The transaction is a primary disclosure; its modest size limits material impact.

02

Market read

Provides fresh insider transaction data for traders monitoring IMAX.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 6/10Novelty 4/10Timing: filing disclosed after market close on 2026-08-24

Background

SEC Form 4 filing reporting an insider sale by IMAX's CFO.

Company-level read

Ticker impact

$IMAXBearishMedium confidence
Context

CFO Natasha Fernandes sold 20,000 IMAX shares for $1.09M on 2026-08-24, reducing her stake to 35,596 shares.

Expected impact

Modest downward pressure in the next trading session.

Evidence & confidence

A $1.1M sale by the CFO is a routine disclosure but can be interpreted as a negative signal; the amount is modest relative to market cap.

Market effects

Minimal impact on the entertainment/technology sector; only a single insider transaction.

No regional effect; confined to IMAX shareholders.

Low global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing unrelated to company outlook.

Key entities

  • IMAX Corp

    Publicly listed entertainment technology company (ticker IMAX).

  • Natasha Fernandes

    Chief Financial Officer and EVP of IMAX.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.

$IMAXMed

'The Odyssey' fuels Imax stock to all-time high. CEO calls momentum a 'flywheel'

Imax shares hit an all-time high Monday, up nearly 6%, after box office momentum from Christopher Nolan’s “The Odyssey.” The company said the film is tracking almost double “Oppenheimer” (2023) and generated $221 million globally, about 25% of Universal’s total. CEO Rich Gelfond attributed results to a “flywheel” of theater expansion and recurring cash flow.